Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Mano Michael, Vice-Président Exécutif, Directeur Juridique et Secrétaire. Director active across 1 company, notably Karyopharm Therapeutics Inc.. In total, 15 reports have been logged. Split: 0 buy · 5 sells. Total volume traded: €71k. History available since 28 February 2022. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations
Michael Mano serves as Executive Vice President, Chief Legal Officer, and Secretary of Karyopharm Therapeutics Inc. He oversees the company's legal affairs and ensures regulatory compliance. With extensive experience in corporate law, he plays a key role in managing legal risks and the company's strategy. Michael Mano is committed to promoting responsible corporate governance practices.